Sanofi, Translate Bio in vaccine pact for covid-19, flu

Must read

How to disable and delete Samsung Pay from your Galaxy phone

When it comes to paying conveniently, Samsung Pay makes using your phone as a bank card an easy process; however, there may come...

How to Hack the Hidden Google Chrome Dinosaur Game

Most of us have seen the dreaded “No Internet” error message on Google Chrome. You can actually turn this screen into a fun,...

These are all the first-party Samsung Galaxy S21 cases & accessories

Samsung has unveiled the Galaxy S21 Series with shiny custom colors, lower prices across the board and the latest camera technology. Once you...

Opera Mini passes 500 million installs on Android

Opera Mini is one of the few applications on Android that predate the existence of Android itself. The web browser got its start...
Bhawani Singhhttps://techmepro.com
I am a blogger who believes in delivering latest tech news from around the world to my viewers.

(Bloomberg) — French drugmaker Sanofi is strengthening its pact with U.S. vaccine developer Translate Bio Inc. to develop shots for Covid-19 and the flu in a deal that could be valued at as much as $2.3 billion.

Sanofi will pay $425 million upfront, partly by acquiring Translate Bio shares at a premium of almost 60%, the companies said Tuesday. The French drugmaker also agreed to pay as much as $1.9 billion upon meeting various goals, plus royalties.


Translate Bio and Sanofi formed an alliance and license agreement in 2018 to develop mRNA vaccines for infectious diseases. The companies are studying several vaccine candidates for Covid-19, aiming to start a clinical trial in the fourth quarter of this year.

Sanofi shares were little changed in Paris trading at 93.03 euros.

The French drugmaker announced plans earlier this month to invest 610 million euros ($690 million) boosting its vaccine business with two new production and research centers in its home market.


Messenger RNA technology is a new approach that tries to defeat a pathogen by injecting ribonucleic acid into the body that then teaches cells to identify and attack the virus.

Sanofi will get worldwide rights for infectious disease vaccines developed in the pact. The companies are also working on shots for influenza and other pathogens.

The upfront payment consists of $300 million in cash and the purchase of $125 million worth of shares at a price of $25.59 each. That’s 58% higher than Monday’s closing price.

About $360 million of the milestone payments are anticipated over the next several years, with the bulk available after that. Translate Bio is based in Lexington, Massachusetts.

Subscribe to newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Source link

More articles

Leave a Reply

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisement -

Latest article

PS5 and Xbox Series X chip shortages will continue until mid-2021, AMD warns

The PS5 and Xbox Series X stock drought looks set to continue until mid-2021, as AMD has warned exceptional demand driven by the...

Supercomputer HPE-Cray EX to Rank Among World’s Fastest; Will Help Study Climate Change, Wildfires, More

A new supercomputer in Wyoming will rank among the world's fastest and help study phenomena including climate change, severe weather, wildfires and solar...

Xiaomi Leads as Indian Smartphone Shipments Near 145 Million in Pandemic-Hit 2020: Canalys

Xiaomi leads as the Indian smartphone market finished 2020 with nearly 145 million units shipped compared to the 148 million smartphones shipped in...

WhatsApp is bringing biometric authentication to WhatsApp Web, Desktop

WhatsApp has announced biometric authentication for Web and Desktop clients.This allows you to use your fingerprint or face to link new devices.WhatsApp has...

Instagram Rolls Out a Multi-Story Carousal Redesign for Stories on Desktop

Instagram is rolling out a new layout for viewing stories on desktop. Instagram Stories appear in a convenient carousel way in the new...
- Advertisement -